Ascendis Pharma A/S (ASND)
NASDAQ: ASND
· Real-Time Price · USD
193.01
-3.65 (-1.86%)
At close: Aug 27, 2025, 3:59 PM
192.71
-0.16%
Pre-market: Aug 28, 2025, 05:39 AM EDT
-1.86% (1D)
| Bid | 185 |
| Market Cap | 11.69B |
| Revenue (ttm) | 490.75M |
| Net Income (ttm) | -271.15M |
| EPS (ttm) | -5.31 |
| PE Ratio (ttm) | -36.35 |
| Forward PE | 50.69 |
| Analyst | Buy |
| Ask | 199 |
| Volume | 364,135 |
| Avg. Volume (20D) | 477,698 |
| Open | 195.83 |
| Previous Close | 196.66 |
| Day's Range | 192.97 - 196.66 |
| 52-Week Range | 111.09 - 199.99 |
| Beta | 0.40 |
About ASND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ASND
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ASND stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Ascendis Pharma A/S is scheduled to release its earnings on
Nov 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+0.6%
Acendis Pharma shares are trading lower following ...
Unlock content with
Pro Subscription
4 weeks ago
+4.03%
Ascendis Pharma shares are trading higher after JP Morgan raised its price target on the stock from $245 to $254.
